CISA added Microsoft SQL Server RCE flaw CVE-2019-1068 to its KEV catalog after confirming active exploitation.

Separating workloads, monitoring compute consumption and applying surge protection can help stabilize Microsoft Fabric performance and control costs.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The onset of the Covid-19 pandemic in March 2020 initiated a seismic reconfiguration of how we work, the speed and scale of which far exceeded any historical precedent. Overnight, kitchens became ...

Share on Pinterest The FDA approved the first nonprescription sale of Dexcom’s continuous glucose monitor for children ages 2 to 18 with diabetes. Svetikd/Getty Images The Food and Drug Administration ...

A metabolic crisis is quietly sweeping through American youths, transforming paediatric prediabetes into one of the country's most urgent health emergencies. Driven by highly sedentary modern ...

FDA Approves First Over-the-Counter Glucose Monitor for Children By Deanna Neff HealthDay ReporterMONDAY, June 15, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has cleared the ...

The FDA has cleared Dexcom, Inc.’s Stelo over-the-counter continuous glucose monitor for children as young as 2 years of age who do not use insulin. The Stelo Glucose Biosensor System was initially ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...

June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has expanded the use of Dexcom's (DXCM.O), opens new tab Stelo Glucose Biosensor ‌System to children with diabetes, making ...